This finding strongly suggests that in other superhuman tasks, such as predicting IDH mutation or MGMT promoter methylation in gliomas, the models are similarly leveraging novel, sub-visual, or complex spatial features that do not map to the traditional morphological lexicon. The gene discussed is IDH1; the disease is glioma.